Paclitaxel and Therapeutic Drug Monitoring with Microsampling in Clinical Practice
Paclitaxel is an anticancer agent efficacious in various tumors. There is large interindividual variability in drug plasma concentrations resulting in a wide variability in observed toxicity in patients. Studies have shown the time the concentration of paclitaxel exceeds 0.05 µM is a predictive para...
Main Authors: | Mirjana Radovanovic, Peter Galettis, Alex Flynn, Jennifer H. Martin, Jennifer J. Schneider |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/17/1/63 |
Similar Items
-
New Trend in Toxicological Screening Using Volumetric Absorptive Microsampling (VAMS) and High-Resolution Mass Spectrometry (HR/MS) Combination
by: Pascal Houzé, et al.
Published: (2023-04-01) -
Therapeutic Drug Monitoring of Antiseizure Medications Using Volumetric Absorptive Microsampling: Where Are We?
by: Annachiara D’Urso, et al.
Published: (2021-06-01) -
Comparison of the capillary and venous blood plasma lipidomes: validation of self-collected blood for plasma lipidomics
by: Ahsan Hameed, et al.
Published: (2025-03-01) -
Dried Volumetric Microsampling Approaches for the Therapeutic Drug Monitoring of Psychiatric Patients Undergoing Clozapine Treatment
by: Camilla Marasca, et al.
Published: (2022-06-01) -
Volumetric Absorptive Microsampling of Blood for Untargeted Lipidomics
by: Camilla Marasca, et al.
Published: (2021-01-01)